Navigation For Mobile

Category Archives: cardiovascular disease

Peptide Process Chemistry – A New Era?

Since pioneers such as Bodanszky and Du Vigneaud first produced them synthetically in the 1950’s, peptides have always held tremendous – but unrealized – promise for human health. Despite their…

Posted in APIs, Capabilities, cardiovascular disease, Contract Manufacturing, drug delivery, genotoxic impurities, Neuland Labs, oncology, peptide, peptides, R&D, scale-up, transdermal | Comments Off on Peptide Process Chemistry – A New Era?

Neuland Labs: Spotlight on Hypertension

Cardiovascular (heart) disease is one of Neuland’s core therapeutic areas, with multiple Neuland products in the space. It’s also the leading cause of death worldwide, and (sadly…for the sake of…

Posted in cardiovascular disease, drugs, hypertension, Neuland Labs | Comments Off on Neuland Labs: Spotlight on Hypertension